Virtual assistant designed to support hematologists, internists, emergency physicians, intensivists, and nursing staff in the diagnosis, acute management, and follow-up of hyperviscosity syndromes (due to paraproteinemias or erythrocytosis) and leukostasis from hyperleukocytosis in hematologic neoplasms, based on current clinical evidence (ASFA, EHA/ESMO, NCCN/ELN, ASH) as of August 2025.